The Effect of Ranibizumab on Eye Lens Opacity in Cases With Age-Related Macular Degeneration

Clinical Trial ID NCT01330797

PubWeight™ 0.00‹?›

🔗 Visit the ClinicalTrials.gov page for NCT01330797

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Randomized, double-masked, sham-controlled trial of ranibizumab for neovascular age-related macular degeneration: PIER Study year 1. Am J Ophthalmol 2008 5.22
2 Complications of intravitreal injections. Curr Opin Ophthalmol 2010 1.63
3 Cataract surgery after intravitreal injection of triamcinolone acetonide. Eye (Lond) 2004 1.46
4 Intravitreal triamcinolone acetonide: a change in a paradigm. Ophthalmic Res 2006 1.20
5 A randomized, controlled trial to investigate the effect of ciclesonide and beclomethasone dipropionate on eye lens opacity. J Asthma 2008 0.82
Next 100